0001486634-19-000002.txt : 20191202 0001486634-19-000002.hdr.sgml : 20191202 20191202153802 ACCESSION NUMBER: 0001486634-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191202 DATE AS OF CHANGE: 20191202 EFFECTIVENESS DATE: 20191202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ReNetX Bio, Inc. CENTRAL INDEX KEY: 0001486634 IRS NUMBER: 270687104 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-354562 FILM NUMBER: 191263207 BUSINESS ADDRESS: STREET 1: 157 CHURCH STREET STREET 2: 19TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: (203) 444-6642 MAIL ADDRESS: STREET 1: 157 CHURCH STREET STREET 2: 19TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 FORMER COMPANY: FORMER CONFORMED NAME: Axerion Therapeutics, Inc. DATE OF NAME CHANGE: 20100309 D 1 primary_doc.xml X0708 D LIVE 0001486634 ReNetX Bio, Inc. 157 CHURCH STREET 19TH FLOOR NEW HAVEN CT CONNECTICUT 06510 (203) 444-6642 DELAWARE Axerion Therapeutics, Inc. Corporation true Erika Smith 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 Executive Officer Director John Puziss c/o Yale University 2 Church Street South, Suite 203 New Haven CT CONNECTICUT 06519 Director David Wurzer c/o Connecticut Innovations,Incorporated 865 Brook Street Rocky Hill CT CONNECTICUT 06067 Director Gregory Ho 650 Madison Avenue 20th Floor New York NY NEW YORK 10022 Director George Maynard 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 Executive Officer Biotechnology Decline to Disclose 06b false 2019-11-27 false true false 0 5500000 1349999 4150001 false 1 0 0 0 No amounts other than ordinary course employment compensation is being paid to officers and directors. false ReNetX Bio, Inc. Erika R. Smith Erika R. Smith Chief Executive Officer 2019-12-02